Skip to main content
. 2014 Mar 12;9(3):e91555. doi: 10.1371/journal.pone.0091555

Figure 5. The ABCB1 1199A variant differentially affects cytotoxicity to doxorubicin and vinblastine.

Figure 5

Cell proliferation after 24h of exposure (N = 4) at six different concentrations of (A) doxorubicin (10–2430 nM) or (B) vinblastine (1.11–270 nM). Graphics are represented by the relative proliferation (%); CPM samples/CPM control (without drugs exposure) *100. * compared to 1199G/WT *p<0.05 **p<0.01 ***p<0.001.